Languages
Pages
Legal
280th OMICS International Conference
Scientific Program
OMICS International Conferences2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA Ph: +1-888-843-8169, Fax: +1-650-618-1417
Email: [email protected]; [email protected]
HepatitisWorld Congress on
July 20-22, 2015 Orlando, Florida, USA
Proceedings of
Exhibitor Collaborator MediaPartners
Page 2
08:00-09:00 Registrations
Prestwack
Day 1 July 20, 2015
Panel Discussion 10:50-11:00Group Photo
Coffee Break 11:00-11:30 @ Lobby NorthSymposium
11:30-12:30New tools of screening viral hepatitis in real life: The French model of careAndre Jean Remy, Perpignan Hospital, France
Track 4: Liver Cancer and Hepatocellular Carcinoma Track 5: Advanced Management of Liver Diseases Track 6: Clinical Liver Transplantation and Liver SurgerySession Chair: Mark A Feitelson, Temple University, USASession Co-Chair: Francisco Antonio Bezerra Coutinho, University of Sao Paulo, Brazil
Session Introduction
12:30-12:55Intermittent hepatic inflow occlusion during partial Hepatectomy for Hepatocellular Carcinoma does not shorten overall survival or increase the likelihood of tumor recurrenceHuang Jiwei, Sichuan University, China
12:55-13:20Advances in HepatologyMaxwell M Chait, Columbia University, USA
13:20-13:45Hedgehog signaling blockade delays Hepatocarcinogenesis induced by Hepatitis B virus X protein
Mark A Feitelson, Temple University, USALunch Break 13:45-14:30 @ Lobby North
14:30-14:55Functional genomics identified a novel cell-cell contact inhibition mechanism involved in HepatocarcinogenesisSen-Yung Hsieh, Chang Gung Memorial Hospital, Taiwan
14:55-15:20Cholesterol-conjugated let-7a mimics: Antitumor efficacy and toxicity in preclinical xenograft models of human Hepatocellular carcinomaJian Guan, Peking Union Medical College Hospital, China
15:20-15:45Crocin, a saffron-based drug, does wonders against Hepatocellular Carcinoma: In vitro, in vivo and in silico approaches Amr Amin, UAE University, UAE
Coffee Break 15:45-16:15 @ Lobby North
16:15-16:40Distinct roles of α-1,2-mannosidase subtypes in Hepatocarcinogenesis: MAN1A1 is an oncogene and MAN1C1 is a tumor suppressor geneChiou-Hwa Yuh, Institute of Molecular and Genomic Medicine, ROC
Keynote Forum
Opening Ceremony08:45-09:15
09:15-09:20 Introduction09:20-09:50 Mark A Feitelson Temple University, USA09:50-10:20 Trent W Nichols AMRI, USA10:20-10:50 Sen-Yung Hsieh Chang Gung Memorial Hospital, Taiwan
Page 3
16:40-17:05Role of Serum glypican-3 in the diagnosis and differentiation of small Hepatocellular carcinoma from Hepatitis-C virus cirrhosis Tarek E Korah, Menoufiya University, Egypt
17:05-17:30Improvement of Hepatitis C related glomerulonephritis after kidney transplantation using Sofosbuvir plus SimeprevirHussein Elseisy, King Faisal Specialist Hospital & Research Center, Saudi Arabia
Panel Discussion 17:30-17:40
Day 2 July 21, 2015Prestwack
Keynote Forum09:00-09:30 Maxwell M Chait Columbia University, USA
Panel Discussion 09:30-09:40Workshop
09:40-10:40The Cirrhosis Micro-environment and Hepato-carcinogenesisSen-Yung Hsieh, Chang Gung Memorial Hospital, Taiwan
Coffee Break 10:40-11:10 @ Lobby NorthTrack 1: Hepatitis: Care and CureTrack 2: Diagnosis and Liver PathologyTrack 3: Assessment of Liver DiseasesSession Chair: Trent W Nichols, AMRI, USASession Co-Chair: Hosny Salama, Cairo University, Egypt
Session Introduction
11:10-11:35Gene up and down-regulation with moderate magnetic fields via toll-receptors and WNT5a; Fatty Liver/NASH Cirrhosis and HCC in “Mice and Men”Trent W Nichols, AMRI, USA
11:35-12:00A decline of LAMP-2 predicts Ursodeoxycholic acid response in Primary biliary cirrhosisJing-Bo Wang, The Fourth Military Medical University, China
12:00-12:25Hepatitis mobile team: A new concept for benefit toward drugs users with Hepatitis CHakim Bouchkira, Hospital of Perpignan, France
12:25-12:50Epidemiological profile of patients at a newer hub of Hepatitis C in IndiaParveen Malhotra, PGIMS, India
12:50-13:15Young Researcher Forum - Profile of viral Hepatitis in Saudi ArabiaAbdullah Abdulrahman Bin Salamah, King Saud University, Saudi Arabia
Panel Discussion 13:15-13:25Lunch Break 13:25-14:10 @ Lobby North
14:10-14:35Hepatitis C virus burden in Egypt and efforts to combatFatma A Amer, Zagazig University, Egypt
14:35-15:00HBV: Challenges to cure in the futureEhab Abd-El-Atty, Menoufia University, Egypt
15:00-15:25Hepatitis B infection during pregnancy - Experience at tertiary care centre of North IndiaVani Malhotra, PGIMS, India
Coffee Break 15:25-15:55 @ Lobby NorthPoster Presentations 15:55-16:25
16:25-16:50Histomorphometric findings may help predict response to antiviral therapy at an Early fibrosis grade in patients with Chronic HCV infectionMayson Abu Raya, Rappaport Faculty of Medicine, Israel
16:50-17:15Effect of isolation measures on the profile of Hepatitis C virus infection in haemodialysis unit of a tertiary care hospitalGarima Mittal, SRHU, India
Panel Discussion 17:15-17:25
Day 3 July 22, 2015PrestwackSymposium
09:00-10:00HCC risk factors synergism in Egypt and how to prevent?Ehab Abd-El-Atty, Menoufia University, Egypt
Track 8: Advancement in New Drug Discovery for Treatment of Hepatitis Track 9: Advance Technologies for the Treatment of Hepatitis and Liver Diseases Track 10: Current Research in HepatologySession Chair: Sen-Yung Hsieh, Chang Gung Memorial Hospital, TaiwanSession Co-Chair: Faustino Bisaccia, University of Basilicata, Italy
Session Introduction
10:00-10:25 Effect of Arabinoxylan rice bran (Biobran) on viremia level in patients with chronic HCV infectionMamdooh Ghoneum, Charles Drew University of Medicine and Science, USA
10:25-10:50Modeling and restoring a defective data base on Hepatitis C Francisco Antonio Bezerra Coutinho, University of Sao Paulo, Brazil
Coffee Break 10:50-11:20 @ Lobby North
11:20-11:45New insight on the Hepatitis B x antigen effector URG7 Faustino Bisaccia, University of Basilicata, Italy
11:45-12:10Effect of Sofosbuvir, brand drug (Sovaldi) versus generic (MPIViropack) in treating chronic HCV infection among Egyptian patients Hosny Salama, Cairo University, Egypt
12:10-12:35Prevalence and risk factors of HBV infection among pregnant women in urban and rural Egyptian communitiesDoa’a A Saleh, Cairo University, Egypt
12:35-13:00Genetic susceptibility of HCV RNA and its genotypic distribution in Punjab, PakistanGhazala Rubi Javaid, Aga Khan University Hospital, Pakistan
Panel Discussion 13:00-13:10Thanks giving & Closing Cermony
Lunch Break 13:30-14:15 @ Lobby North
OMICS Group Inc.2360 Corporate Circle, Suite 400Henderson, NV 89074-7722, USA
Ph: +1-888-843-8169Fax: +1-650-618-1417
OMICS Publishing Group5716 Corsa Ave., Suite 110, Westlake
Los Angeles, CA 91362-7354, USAPh: +1-650-268-9744Fax: +1-650-618-1414
OMICS GroupSEZ Unit, Building No. 20, 9th Floor
APIIC Layout, HITEC CityHyderabad-500081, Telangana, INDIA
Ph: 040-40131823, [email protected]
Toll freeUSA & Canada: +1-800-216-6499
Australia: +1-800-651-097Europe: 0805-080048
e-mail: [email protected]; [email protected] Website: hepatitis.omicsgroup.com
World Congress on
Hepatitis & Liver DiseasesBookmark your dates
October 17-19, 2016 Dubai, UAE
Top Related